Menu
GeneBe

8-9003113-C-A

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_153332.4(ERI1):c.50C>A(p.Ala17Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000914 in 1,093,656 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A17S) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 34)
Exomes 𝑓: 9.1e-7 ( 0 hom. )

Consequence

ERI1
NM_153332.4 missense

Scores

2
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.183
Variant links:
Genes affected
ERI1 (HGNC:23994): (exoribonuclease 1) Enables 3'-5' exonuclease activity. Predicted to be involved in exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA). Located in cytoplasm and nucleolus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.09720352).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ERI1NM_153332.4 linkuse as main transcriptc.50C>A p.Ala17Glu missense_variant 1/7 ENST00000250263.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ERI1ENST00000250263.8 linkuse as main transcriptc.50C>A p.Ala17Glu missense_variant 1/71 NM_153332.4 P1
ERI1ENST00000519292.5 linkuse as main transcriptc.50C>A p.Ala17Glu missense_variant 1/82 P1
ERI1ENST00000520684.5 linkuse as main transcriptc.50C>A p.Ala17Glu missense_variant, NMD_transcript_variant 1/65
ERI1ENST00000521844.1 linkuse as main transcriptc.50C>A p.Ala17Glu missense_variant, NMD_transcript_variant 1/34

Frequencies

GnomAD3 genomes
Cov.:
34
GnomAD4 exome
AF:
9.14e-7
AC:
1
AN:
1093656
Hom.:
0
Cov.:
34
AF XY:
0.00000193
AC XY:
1
AN XY:
517358
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000108
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
34

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 25, 2023The c.50C>A (p.A17E) alteration is located in exon 1 (coding exon 1) of the ERI1 gene. This alteration results from a C to A substitution at nucleotide position 50, causing the alanine (A) at amino acid position 17 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Benign
-0.53
Cadd
Benign
13
Dann
Benign
0.55
DEOGEN2
Benign
0.069
T;T;T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.061
N
M_CAP
Benign
0.0036
T
MetaRNN
Benign
0.097
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.34
N;N;N
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
0.84
N;N;N
REVEL
Benign
0.073
Sift
Uncertain
0.016
D;D;D
Sift4G
Benign
0.16
T;T;T
Polyphen
0.18
B;B;B
Vest4
0.37
MutPred
0.13
Gain of solvent accessibility (P = 0.1319);Gain of solvent accessibility (P = 0.1319);Gain of solvent accessibility (P = 0.1319);
MVP
0.061
MPC
0.0082
ClinPred
0.16
T
GERP RS
1.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.064
gMVP
0.44

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr8-8860623; API